Marketwired .

Subscribe to Marketwired .: eMailAlertsEmail Alerts
Get Marketwired .: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


Top Stories by Marketwired .

GARDENA, CA--(Marketwired - April 26, 2018) - Polar Power, Inc. (NASDAQ: POLA), a global provider of prime, backup and solar hybrid DC power solutions, will hold a conference call on Monday, May 14, 2018 at 4:30 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2018. Financial results will be issued in a press release prior to the call. Polar Power CEO Arthur Sams, CFO Luis Zavala and COO Raj Masina will host the conference call, followed by a question and answer period. To access the call, please use the following information: D a tMonday, May 14, 2018 e : T i m e4:30 p.m. ET, 1:30 p.m. PT : T o l l - f r e e d i a1-800-239-9838 l - i n n u m b e r : I n t e r n a t i o n a l d i1-323-794-2551 a l - i n n u m b e r : C o n f e r e n8981569 c e I D : Please call the conference telephone number 5-10 minutes prior to the start time. An operat... (more)

Olivier Benloulou Acquires Common Shares of Indiva Limited

GATINEAU, QUEBEC -- (Marketwired) -- 12/27/17 -- Olivier Benloulou ("Mr. Benloulou"), through 4098242 Canada Inc. ("409"), a corporation wholly owned and controlled by Mr. Benloulou, acquired 8,800,000 common shares (collectively, the "Acquired Shares" and each, an "Acquired Share") of Indiva Limited (the "Issuer"). The Acquired Shares represent approximately 14.44% of issued and outstanding Common Shares of the Issuer. On December 13, 2017, the Issuer completed its acquisition of 100% of the issued and outstanding securities of Indiva Corporation ("Indiva") by way of a "three-c... (more)

Moleculin Announces New Data for Immuno-Stimulating Drug to be Presented at International Conference

HOUSTON, TX--(Marketwired - April 26, 2018) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced that Dr. Waldemar Priebe, Chair of the Company's Scientific Advisory Board, has been selected to present findings on Moleculin's STAT3 inhibitor and immuno-stimulating agent, WP1066, at the Global Academic Programs 2018 in Stoc... (more)

WSP Announces Details for Its Annual Meeting of Shareholders and Release of 2018 First Quarter Results

MONTREAL, QUEBEC -- (Marketwired) -- 04/26/18 -- WSP Global Inc. (TSX: WSP) ("WSP" or the "Corporation") will host its annual meeting of shareholders and release its 2018 first quarter results on Thursday, May 10, 2018. ANNUAL MEETING OF SHAREHOLDERS The annual meeting of shareholders will be held at the Fairmont Queen Elizabeth, 900 Rene-Levesque Blvd. West, in Montreal at 10 a.m. (Eastern Time). During the meeting, WSP will discuss its 2017 performance and its 2018 strategy. For those who are unable to attend in person, the Corporation will webcast the meeting live on its websi... (more)

WSP Announces Details for Its Annual Meeting of Shareholders and Release of 2018 First Quarter Results

MONTREAL, QUEBEC -- (Marketwired) -- 04/26/18 -- WSP Global Inc. (TSX:WSP) ("WSP" or the "Corporation") will host its annual meeting of shareholders and release its 2018 first quarter results on Thursday, May 10, 2018. ANNUAL MEETING OF SHAREHOLDERS The annual meeting of shareholders will be held at the Fairmont Queen Elizabeth, 900 Rene-Levesque Blvd. West, in Montreal at 10 a.m. (Eastern Time). During the meeting, WSP will discuss its 2017 performance and its 2018 strategy. For those who are unable to attend in person, the Corporation will webcast the meeting live on its websit... (more)